Oct 3 Expert Speaker: Roshni Kulkarni, MD
Dr. Roshni Kulkarni, currently Professor Emerita of Pediatrics and Human Development at Michigan State University, has an exceptional career. She previously directed the Center for Bleeding and Clotting Disorders and Pediatric Hematology/Oncology (PHO) and served as Director of the Division of Blood Disorders at the CDC in Atlanta, GA.
Dr. Kulkarni, a graduate of Osmania Medical College, Hyderabad, India, completed her residency and fellowship at Children's Hospital of Michigan, Detroit, MI. She is a founding member of the Foundation for Women and Girls with Blood Disorders and contributes to CDC and National Hemophilia Foundation committees.
Her contributions include securing federal grants for outreach and telemedicine/telegenetics clinics and serving as a reviewer for esteemed journals. Dr. Kulkarni's accolades include the Hemophilia Foundation of Michigan's "Fairy Godmother to Women with Hemophilia," the American Journal of Hematology's "Women Leaders in Hematology," NHF's "Physician of the Year," MSU's "Distinguished Faculty," and the Federal Drug Administration and CDC
"Distinguished Service" awards.
Topic: Recognizing and Representing Women with Bleeding Disorders In our upcoming discussion on the diagnosis and care of women and girls with bleeding disorders, Dr. Kulkarni will underscore the importance of early diagnosis.
She will emphasize the use of genotyping and factor levels, and the complexities that arise when symptom severity does not align with factor levels.
During this presentation we will learn more about:
Under-Recognition of Symptoms: Discover why women with mild or moderate hemophilia often delay seeking care for symptoms like heavy menstrual bleeding or postpartum hemorrhage, and how these symptoms are frequently downplayed in favor of others' needs.
Strategies for Improved Outreach and Diagnosis: Learn effective approaches to ensure early diagnosis, appropriate treatment, and the prevention of complications for women and girls with bleeding disorders.
Representation in Registries: Understand the importance of including women and girls in registries, especially those without access to specialized treatment centers, and how this can enhance diagnosis and treatment outcomes.
By understanding these key issues, we'll all be better prepared to self-advocate and support the women and girls in our lives who are affected by bleeding disorders.